GSK said it has bought Aiolos Bio for an upfront consideration of $1 billion, with the potential for an additional $400 million.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » GSK Expands Respiratory Pipeline With Aiolos Bio Buy